Key result
COVID-19 links to myocardial injury and arrhythmias exacerbated by advanced age and prior CV conditions.
Why the study?
COVID-19 can present with a variety of cardiac manifestations that are worse in patients with pre-existing cardiac conditions or predisposing risk factors.
This review summarizes the cardiovascular epidemiology, pathogenesis, clinical manifestations, and management of COVID-19.
Cardiac monitoring may be prudent in older COVID-19 patients with CVD; leaves open optimal preventive strategies.
Coronavirus Disease 2019 (COVID-19) is a rapidly progressing global pandemic that may present with a variety of cardiac manifestations including, but not limited to, myocardial injury, myocardial infarction, arrhythmias, heart failure, cardiomyopathy, shock, thromboembolism, and cardiac arrest. These cardiovascular effects are worse in patients who have pre-existing cardiac conditions such as coronary artery disease, hypertension, diabetes mellitus, and coagulation abnormalities. Other predisposing risk factors include advanced age, immunocompromised state, and underlying systemic inflammatory conditions. Here we review the cellular pathophysiology, clinical manifestations and treatment modalities of the cardiac manifestations seen in patients with COVID-19.
No takes yet. Share an insight, caveat, or question.
Sattar et al. (2020) conducted a review in COVID-19 with cardiac manifestations. COVID-19 presents with various cardiac manifestations, including myocardial injury and arrhythmias, which are exacerbated by pre-existing cardiovascular conditions and advanced age.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: